Retham Technologies
Wauwatosa
About Retham Technologies
Retham Technologies is a biotech business that enables HIT testing to diagnose heparin-induced thrombocytopenia. They develop an IVD assay for patient HIT diagnosis is expected to facilitate timely and appropriate therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $100.0K
- Last round: Grant (Dec 2022)
- Website: rethamtechnologies.com
- Phone: (347) 346-3423
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/retham-technologies-142390 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.